Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Aspirin protects against colorectal cancer, says international clinical trial

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 21 Sep 2009

Views: 13058

Rating:

Save

Professor John Burn, Institute of Human Genetics, Newcastle University, UK

Aspirin protects against colorectal cancer, says international clinical trial. Press conference from ECCO 15 ESMO 34, Berlin.

Categories:
Colorectal & gastro

Related Videos

IORT at hospital Del Mar Barcelona in Spain

Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain

IORT at hospital Del Mar Barcelona in Spain ( Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain )

IORT at University Hospital Augsburg in Germany

Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany

IORT at University Hospital Augsburg in Germany ( Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany )

Trifluridine/tipiracil plus bevacizumab improves OS in mCRC

Dr Josep Tabernero - Vall d’Hebron University Hospital, Barcelona, Spain

Trifluridine/tipiracil plus bevacizumab improves OS in mCRC ( Dr Josep Tabernero - Vall d’Hebron University Hospital, Barcelona, Spain )

Navigating evidence-based care with limited resources in Africa

Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine...

Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )

Exploring prevention and early detection of cancer to the Choosing Wisely...

Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda

Exploring prevention and early detection of cancer to the Choosing Wisely initiative ( Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda )

Choosing Wisely in implementing prevention, screening and early detection...

Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda

Choosing Wisely in implementing prevention, screening and early detection programs in Africa ( Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda )

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy...

Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer ( Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA )

HER-Vaxx is safe and provides clinical benefit over standard of care chemo for...

Dr Tanuj Chawla and Dr Giovanni Selvaggi

HER-Vaxx is safe and provides clinical benefit over standard of care chemo for patients with HER2-overexpressing gastric cancer ( Dr Tanuj Chawla and Dr Giovanni Selvaggi )

Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and...

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan

Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and OS in CLDN18.2+/ HER2 mG/GEJ adenocarcinoma ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )

More from ecancer